SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending amidst strong revenue performance, an influx of new strategic partnerships with global mobile operators, and multiple analyst price target upgrades. The community is actively celebrating this commercial validation and robust financial runway, anticipating a short squeeze and continued upward momentum for its direct-to-device satellite network.

Kraken Robotics, Inc. engages in the design, manufacture, and sale of software-centric sensors, subsea batteries, thrusters and underwater robotic systems. It operates through the following geographical segments: Asia Pacific, Europe, Middle East and Africa, North America, and Other. The company was founded on May 14, 2008, and is headquartered in Mt. Pearl, Canada.

Kraken Robotics Inc

Kraken Robotics is making waves with its transformative acquisition of Covelya Group, a deal poised to establish it as a dominant force in subsea technology and integrated underwater autonomy solutions. The community is actively debating the short-term impact of share dilution versus the substantial long-term growth and strategic advantages this vertical integration brings, especially given rising defense spending.

Hydrograph Clean Power, Inc. engages in the research, development, marketing and commercialization of patented technology to produce pristine graphene, graphene derivatives and services. The company was founded by Harold Charles Davidson on June 26, 2017 and is headquartered in Vancouver, Canada.

Hydrograph Clean Power Inc

Hydrograph Clean Power is trending following key regulatory clearances for its high-purity graphene in major global markets, alongside an operational production facility. The community is buzzing with enthusiasm over the company's unique material technology and strategic positioning to capture significant demand across diverse industries, eagerly anticipating upcoming commercial milestones.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SLS is surging as investors eagerly await imminent Phase 3 REGAL trial results for its AML therapy, GPS, anticipating groundbreaking success that could trigger a significant short squeeze or major pharma buyout. The community believes extended trial duration and previous data signal strong patient outcomes, positioning the stock for a major repricing.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is highly active amid market uncertainty driven by escalating US-Iran tensions impacting oil prices and persistent debates over tech valuations and AI's disruptive potential. Community sentiment is polarized, with aggressive dip-buying contrasting with concerns about further downside for this leveraged Nasdaq 100 ETF.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

Rigel Pharmaceuticals is trending after reporting a significant Q4 2025 EPS beat, strong revenue growth, and positive 2026 guidance, alongside promising R289 pipeline data. Despite these strong financial results and a perceived low valuation, the stock's puzzling market reaction is fueling community frustration, high short interest, and ongoing buyout speculation within the biotech sector.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

FNMA is trending as investors grapple with uncertainty over its release from government conservatorship, fueled by recent directives for substantial mortgage bond purchases that suggest continued federal control over privatization. Community discussion highlights frustration over perceived delays and potential share dilution, while long-term holders maintain optimism due to the company's consistent profitability.

GitLab, Inc. engages in the intelligent DevSecOps platform for software innovation. The firm enables organizations to increase developer productivity, improve operational efficiency, reduce security and compliance risk, and accelerate digital transformation. The company was founded by Dmitriy Zaporozhets and Sid Sijbrandij in 2011 and is headquartered in San Francisco, CA.

Gitlab Inc - Ordinary Shares - Class A

Gitlab Inc

GitLab is trending after reporting solid quarterly results that were overshadowed by a conservative fiscal year 2027 guidance, causing a significant stock dip. While bulls see the new $400 million share repurchase and AI-driven platform potential as strong buy signals, bears point to slowing growth and increased competition within the software sector.

United States Commodity Funds LLC - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending as escalating geopolitical tensions from US-Israeli strikes on Iran and retaliatory attacks severely disrupt shipping in the Strait of Hormuz, fueling community debate between expectations of sustained oil price surges and predictions of a swift de-escalation.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending amidst community debate over competitor Roche's Fenebrutinib trial data, contrasting its safety concerns with Briumvi's strong long-term efficacy, recently reinforced by JAMA Neurology publication. The stock is also gaining visibility from a national MS awareness campaign with Christina Applegate, while investors await upcoming earnings and discuss the implications of rising short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$MYRG Q4 &#39;25 Earnings Results &amp; Recap

• Reported GAAP EPS of $2.35 up 137.37% YoY
• Reported revenue of $973.54M up 17.32% YoY
• MYR Group Inc. anticipates continued positive impact from infrastructure spending in T&amp;D and C&amp;I markets, with large multi-year projects not significantly affecting 2026 results, but expects increased distribution market opportunities.

Stocktwits

MYR Group Inc

 Q4 '25 Earnings Results & Recap

• Reported GAAP EPS of $2.35 up 137.37% YoY
• Reported revenue of $973.54M up 17.32% YoY
• MYR Group Inc. anticipates continued positive impact from infrastructure spending in T&D and C&I markets, with large multi-year projects not significantly affecting 2026 results, but expects increased distribution market opportunities.